Surgery Partners’ (SGRY) “Overweight” Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Surgery Partners (NASDAQ:SGRY) in a report published on Tuesday morning, Benzinga reports. Cantor Fitzgerald currently has a $43.00 price target on the stock.

Several other research firms have also recently commented on SGRY. Benchmark reaffirmed a buy rating and issued a $50.00 price objective on shares of Surgery Partners in a research report on Wednesday, May 1st. Citigroup cut their price objective on shares of Surgery Partners from $42.00 to $38.00 and set a buy rating on the stock in a research report on Wednesday, May 8th. Macquarie began coverage on shares of Surgery Partners in a research report on Friday, June 28th. They issued an outperform rating and a $31.00 price objective on the stock. Finally, StockNews.com raised shares of Surgery Partners from a sell rating to a hold rating in a research report on Thursday, March 21st. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Surgery Partners currently has a consensus rating of Moderate Buy and a consensus price target of $40.14.

Surgery Partners Trading Up 8.7 %

Shares of NASDAQ SGRY opened at $25.55 on Tuesday. The company’s fifty day moving average is $25.26 and its 200-day moving average is $28.33. The stock has a market cap of $3.25 billion, a price-to-earnings ratio of 27.34, a P/E/G ratio of 1.78 and a beta of 2.78. Surgery Partners has a twelve month low of $22.05 and a twelve month high of $44.88. The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 0.92.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.04 by $0.02. The business had revenue of $717.40 million for the quarter, compared to analysts’ expectations of $707.66 million. Surgery Partners had a net margin of 0.02% and a return on equity of 3.65%. Equities research analysts predict that Surgery Partners will post 0.88 EPS for the current year.

Insider Activity at Surgery Partners

In other Surgery Partners news, insider Bradley R. Owens sold 6,000 shares of the stock in a transaction that occurred on Friday, May 31st. The shares were sold at an average price of $27.65, for a total transaction of $165,900.00. Following the transaction, the insider now owns 72,338 shares in the company, valued at approximately $2,000,145.70. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 2.30% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. Strs Ohio acquired a new position in shares of Surgery Partners during the 4th quarter worth approximately $51,000. DekaBank Deutsche Girozentrale lifted its holdings in shares of Surgery Partners by 102.0% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock worth $80,000 after acquiring an additional 1,375 shares during the period. Mesirow Institutional Investment Management Inc. lifted its holdings in shares of Surgery Partners by 12.4% during the 4th quarter. Mesirow Institutional Investment Management Inc. now owns 3,388 shares of the company’s stock worth $108,000 after acquiring an additional 373 shares during the period. Headlands Technologies LLC bought a new stake in shares of Surgery Partners during the 4th quarter worth approximately $145,000. Finally, EntryPoint Capital LLC lifted its holdings in shares of Surgery Partners by 257.1% during the 1st quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock worth $191,000 after acquiring an additional 4,607 shares during the period.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.